Saltar al contenido
Merck

Immune induction and modulation in mice following immunization with DNA encoding F protein of respiratory syncytial virus.

Molecules and cells (2001-09-20)
E K Park, B Y Soh, Y S Jang, J H Park, G H Chung
RESUMEN

Respiratory syncytial virus (RSV) is one of the principal agents of bronchiolitis and pneumonia in young children. Thus, there is a strong need to make a safe and effective vaccine against the RSV infection. DNA immunization is very effective at inducing both cellular and humoral immune responses. In this study, we inserted the RSV-F gene into expression vectors, pcDNA3.1 and pQE. These constructs were transformed into C2C12 and E. coli M15 cells, respectively. The expression of the RSV-F protein was confirmed by SDS-PAGE, followed by Western blot analyses. The immunization of pcDNA3.1-RSV-F elicited both anti-RSV-F titer in mouse sera and CTL activities with mouse splenocytes. Especially, the co-administration of IL-4, or the GM-CSF gene with the RSV-F gene construct, enhanced the production of anti-RSV-F Ab. However, this enhancement disappeared by the simultaneous injection of the Th1 and Th2 type cytokine genes. The CTL activities were affected by the co-delivery of the IFN-gamma gene, but not by Th2-type cytokines.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Anti-RSV Antibody, fusion protein, all type A, B strains, clone 133-1H, ascites fluid, clone 133-1H, from mouse